Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Recent Articles in IPO/Stock Watch

InnoCare (Beijing) Prices Hong Kong IPO at Top of Range, Raises $288 Million
Legend, a Nanjing CAR-T Biotech, Files for a US IPO
Bio-Thera, an Antibody Company, Prices $241 Million Shanghai STAR Board IPO
AkesoBio Files for $300 Million Hong Kong IPO to Develop Antibody Portfolio
I-Mab Completes $104 Million NASDAQ IPO to Develop Biologics Portfolio
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China